Kate Rochlin's most recent trade in IN8bio Inc was a trade of 12,295 Series A Warrants (right to buy) done . Disclosure was reported to the exchange on April 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 12,295 | 12,295 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 12,295 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 27 Apr 2025 | 12,295 | 55,169 | - | 0.2 | 2,267 | Common Stock |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 12,295 | 12,295 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 12,295 | 0 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2025 | 12,295 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 338,950 | 338,950 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Rochlin Kate | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 302,839 | 302,839 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 25,316 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 42,874 | - | - | Common Stock | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 12,295 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 12,295 | 12,295 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Kate Rochlin | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 186,000 | 186,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Rochlin Kate | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 12,295 | 12,295 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 12,295 | 12,295 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Rochlin Kate | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 12,295 | 17,558 | - | - | Common Stock | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 67,800 | 67,800 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 60,555 | 60,555 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 16 Aug 2022 | 5,263 | 5,263 | - | 1.9 | 10,000 | Common Stock |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 96,000 | 96,000 | - | - | Employee Stock Option (right to buy) |